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Abstract 
In studies that have explored the problem of medical non-compliance, i.e. where patients do 
not adhere to a prescribed regime is a significant and complex problem (Eraker et al, 1984), it is 
estimated that non-compliance with short-term medication regimes can be as high as 92% 
with an average of 50% for some chronic diseases (Bergman and Werner, 1963).  In their review 
paper Eraker et al list a series of possible reasons for non-compliance such as the patients 
world-view, patient knowledge and experience, social interactions, social and demographic 
factors along with issues surrounding the training of healthcare professionals.   
Roter et al (1998) undertook a meta-analysis of compliance research across a range of health 
issues and intervention types.  The study showed again, that the issue of compliance is complex 
and that no single intervention strategy works across the board and that success can depend 
on the condition being treated and the relationship between the doctor and the patient. 
With the advent of the World Wide Web, interactive technologies and the advent and use of 
smartphones, there exists the potential to examine the use of this technology as an aid to 
medical compliance, in particular the improvement of medication regimes. Current digital 
technology to aid compliance is largely in the form of downloadable 'Apps' that allow a user to 
register and monitor their pill usage. 
This paper outlines work on a feasibility study looking at the use of Augmented Reality (AR) to 
provide support and supplementary information to patients undergoing various medication 
regimes. Using interviews and observation techniques the study contrasts and compares the 
patient experience and compliance data between using the AR and undertaking their 
'standard' medication regime. The paper discusses the feasibility of using image recognition AR 
and proposes routes forward for this technology in aiding medical compliance.  
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Introduction  
According to a 2014 OFCOM independent report on the uptake of telecommunications devices 
the ownership of smart phones and computer tablets continues to grow in the UK, with six out of 
ten people now claiming to own a smart phone and 44% of households owning a tablet computer, 
almost double the figure from the previous year (OFCOM 2014). According to the OFCOM report 
14% of people aged 65-74 now own a smart phone and one in five aged 65+ owns a computer 
tablet. This increase has facilitated a rise in mobile web access and the engagement in social media, 
which retailers and brand owners have been quick to capitalise on, increasingly looking for new, 
‘interactive’ ways with which to engage customers. Initially the integration of the digital has been 
achieved by simple strategies such as packaging having links to websites or Facebook pages. 
These links typically provide more information about a product, such as nutritional information 
and dietary advice or value added content like recipes, discounted offers, competitions, games 
and digital media. The links also connect the purchaser to likeminded consumers and networks 
where related social-cultural or aspirational content and ideas can be shared.  
As well as the potential of connecting to consumer communities, retailers have begun to take 
advantage of improvements in computing power and hardware and software capabilities. For 
example, the embedding of microchips in packaging to track freshness and provenance (Trebar, 
2014) and the use of smart phones and tablets to offer more advanced technological interaction 
with products and their packaging. 
Examples of this type of digital technology, used to aid and support medical compliance, can be 
seen through the development of smartphone 'Apps' such as 'Medi-Track Lite', 'Pill Monitor' and 
'DoseBox'. These smartphone 'Apps' vary in complexity and visual design. Generally the 'Apps' at a 
basic level provide users with alert reminders to take specific medication, whilst the more 
sophisticated 'Apps' may provide pictures of the required medication to aid identification, provide 
supporting information on the medication and e-mail the patient's Doctor. 
Augmented Reality (AR) 
AR is beginning to be used within the context of domestic packaging as a means of connecting to 
the potential of the digital to enhance both experience and information.  Although digital AR 
technologies have been around since the 1960s continuing technical developments in the last 20 
years combined with a recent increase in the awareness of AR in the public domain means that we 
are only now beginning to see the more commonplace use of AR (Bimber, & Raskar, 2005).  In 
simple terms AR is the overlaying or mapping of digital content into a real environment or onto a 
physical object. This is typically achieved using the built in camera and digital screen of a smart 
phone or tablet together with propriety software to combine the video image of a real space or 
object with additional digital information (see Fig.1).  
	  
	  
Proceedings of the Third European Conference on Design4Health 2015, Sheffield, 13 - 16 July 2015 
ISBN 978-1-84387-385-3 
	  
3	  
 
 
Figure	  1:	  AR	  content	  shown	  on	  a	  tablet	  computer	  (image	  Laura	  Drew	  2015)	  
Importantly AR technologies are capable of recognising and placing digital content in a specific 
place within a physical environment or in a predefined position in relationship to a physical object. 
This makes it possible to build a logical connection between the virtual digital material and 
context in which it is placed. From the user’s perspective there are two main ways in which AR can 
be viewed. These are either through the screen of a hand-held device, such as a mobile phone or 
tablet computer or through the use of a head mounted display. Using either technique AR 
provides the user with an enhanced view of a physical environment or object with computer 
generated graphics or imagery, animation or audio. But unlike the concept of Virtual Reality (VR) 
where the user is ‘immersed’ in a digital environment, AR allows the user to retain a connection 
with their real-world location and experience, allowing the augmented experience the potential to 
connect to lifestyles and daily routines (Fig 2.).  
 
 
Figure	  2:	  A	  comparison	  between	  Augmented	  Reality	  (AR),	  (left)	  and	  Virtual	  Reality	  (VR),	  (right).	  (Diagram	  
concepts	  by	  Mark	  Billinghurst	  from	  The	  Human	  Interface	  Technology	  Laboratory,	  New	  Zealand).	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Traditionally, AR is triggered when a digital device recognises a printed marker in the environment. 
The most common form of marker is the ‘QR’ or Quick Response code, which can be seen on 
various pieces of packaging and printed materials. QR codes are small 2D black and white coded 
images (a form of bar code), which usually connects to a website (via an embedded hyperlink) 
when a user scans the code with a smart phone or tablet device. The use of QR codes has become 
widespread on Fast-Moving-Consumer-Goods (FMCG) packaging but has limited application on 
Over-The-Counter (OTC) medicines and is largely non-existent on prescription medical packaging. 
Despite the prevalence of QR codes on FMCG packs, initial work by the authors (part of a separate 
study) has shown their use by consumers to be extremely limited to almost non-existent. Where 
users did engage with packaging related digital content, this was often through the typing of the 
brand web address rather than scanning the QR code. 
However, with advancements in AR and mobile technologies it is now possible to trigger the 
placement of digital content by recognising specific objects such as the shape of a piece of 
packaging, or particular illustrations or graphics printed on a product. These enabling 
technologies mean that the AR experience of digital content can be more integrated as a user 
interacts with packaging. This immediacy along with development of more tailored and engaging 
digital content has the potential for improving a user's interaction with prescribed medication 
compliance and engagement with their medical conditions.   
Designing for AR medicine packaging 
As we have discussed AR technologies allow for the user’s current situation or environment to be 
overlaid with the addition of supplementary information and graphically designed digital content. 
This research examines how the capabilities of AR can be applied in the context of medicine 
packaging in a way that might lead to the better use of prescribed pharmaceuticals and increased 
awareness and understanding of how and when medication should be taken. An initial survey of 
current practices has shown that much of the existing AR connectivity is based on the use of QR 
codes found on packaging that directs the user to an external company website. 
In the following design tests experiments were undertaken to see if AR might be used to A: more 
actively promote user engagement and interaction using a number of digital media forms and B: 
examine the impact of different interface designs and architectures to present information and 
user profile data and schedules, specifically reminders of when to take medication or to specify 
appropriate dosages etc.  
A variety of AR prototype designs have been developed to enable user-testing activities in this 
study and existing applications which attempt to offer these types of services not using the 
concept of AR are commented on in the following sections. 
Research Methods  
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For this feasibility study we have focused on the use of hand-held mobile devices. In this initial 
study four participants were selected with varying degrees of wellbeing requiring prescription or 
OTC medicine use and compliance. Users were recruited through existing research networks 
within the ADRC at Sheffield Hallam University (SHU). Ethics approval was obtained through SHU 
ethics committee and all data was anonymised and stored in accordance with SHU data protection 
guidelines.  
Several meetings were held with each participant to discuss their current medical packaging use, 
issues and compliance using a semi-structured interview and questionnaire.  The participants, 
three females and one male, were aged between 22 to 72 years and had a range of conditions 
from Glaucoma and Rheumatoid Arthritis, Crohn's Disease, anxiety and high blood pressure.  At 
the meetings participants were asked questions around the medication they took, their general 
routine, their interactions with family and healthcare professionals and the understanding of their 
condition. The participants were also asked for their views and preferences for visual images and 
graphics to inform the development of an AR interface design. 
From these semi-structured interviews a series of concept maps were produced for each 
participant outlining their needs/wants and current usage of their medication (Fig 3.). 
 
	  
Figure	  3:	  Concept	  map	  following	  interviews	  of	  a	  participant	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These concept maps produced four distinct outcomes for the users; 
• Participant A needs a gentle reminder to take tablets on a regular basis. User resonates 
mostly with friendly images of herself, partner or her/friends and family. 
• Participant B needs a friendly interface design incorporating information about 
supplementary medication, where to buy it and contacts for friendly support groups. 
• Participant C requires a reminder system for taking each type of medication as well as 
information about them. User resonates with medical professional imagery as well as 
friendly faces. 
• Participant D wants a clear reminder system with structured alerts for taking tablets and 
information about which one needs to be taken with food. User resonates best with 
medical professionals. 
Typical quotes from the participants were: 
"I do forget. Particularly at night. I forget how many I've taken. It would be nice to have 
something to remind me and engage me and also help my partner." - Participant A 
"I do take my medication regularly. I don't understand it all though and I take all these 
supplements but I like to read all about it and read about the benefits in magazines etc" - 
Participant B 
"I just forget and can't be bothered. I've never really had my condition explained to me 
really, or what happens if I don't take them." - Participant C 
All participants had access to smartphones, however the older participant (Participant B) was less 
comfortable using the technology. None of the participants had previously used smartphone 
technology such as 'Med-track' or 'DoseBox'. 
Outcomes 
Following the production of the concept maps an iterative process of AR interface design was 
undertaken with each user to ascertain a level of interactivity and usefulness that was appropriate 
for that particular user. Initial stages looked at differing layouts and interactivity options such as 
calendars, interface design, animations and other elements of digital content. 
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The initial concepts had a similar look and feel to existing  'Apps' and performed in a similar 
fashion. The main difference being that the information provision and ability to interact with 
information was triggered by the pack itself. Whilst of interest this approach moved away from the 
truly interactive approach of AR, whereby there was interaction with the pack and the information. 
In a series of secondary meetings participants were questioned again about the use of the 
smartphone 'Apps' and the look and feel that the AR interfaces might have when working with the 
physical packaging in view. 
From this round of secondary interviews a series of interfaces were developed. An example for 
participant C is shown in Fig 4.   
 
 
Figure	  4:	  AR	  interaction	  with	  medication	  pack	  
Various themes were developed that were specific to each participant but which had similar 
thematic elements such as the iconography identifying the item in question (as shown above in 
Fig 4.)  All the participants were asked to test the interfaces against their current usage, work for 
which is still ongoing. However initial results show significant scope for behavioural change when 
these AR mobile technologies are combined with other elements of a user's digital lifestyle. For 
example minor changes to one of the AR links gave the participant digital rewards for using and 
engaging with the interface, something that they had enjoyed and experienced previously with a 
weight loss 'App'. 
Conclusion   
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As Steven Benford describes, AR technologies can be used to label physical objects with 
instructions, give guidance and directions and even populate the physical with virtual characters 
and objects (Benford, 2002). This work has begun to show that AR technologies can be successfully 
used on medicine packaging and may possibly aid with improved compliance. 
The initial small-scale study shows that in order for this technology to work the AR content and 
experience will need to be personalised to the individuals needs. However, how and why people 
take medication is a complex issue and what role AR might take in motivating people to take their 
medication needs to be looked at in more detail. There are of course other issues raised by the 
work. For example how the user will identify the medication pack has some AR functionality when 
the technology no longer requires the visual cue of a QR code, and other issues around technical 
understanding. In this study Participant B was an older woman with high blood pressure and 
arthritis who had a low level of technical competency with her smartphone. She found the AR 
'fascinating' and fun and it was presented in a way that engaged her (this user liked to read 
magazines so the interface played on the theme of newspapers), however how this would work for 
other users of low competency remains unclear. Finally the source of information that is linked to 
the packaging has to be reliable and robust. This may be true for all applications of this type 
(including 'Apps') and so care may need to be taken. 
Clearly the concept of AR has significant potential to aid understanding and engagement with 
packaging and in this instance medication.  However, integrating it into users regimes and current 
healthcare provision systems is a complex issue that requires significant understanding before the 
augmentation really will become a reality. 
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